Forgot your password?
KRP-M223 is being developed for CSU and other allergic and inflammatory diseases
Up to 20% of children and 10% of adults globally are affected by the skin disease
The immune-mediated skin disease impacts over 125 million people worldwide
The Stelara biosimilar has been authorised to treat plaque psoriasis and psoriatic arthritis
At least 100 million people worldwide are affected by some form of psoriasis
There is currently only one treatment authorised for dystrophic epidermolysis bullosa
The drug has been approved to treat both atopic dermatitis and prurigo nodularis
The company said the data confirms the approach for its approved phase 3 diabetic foot infections study
If approved, Dupixent would be the first and only targeted medicine to treat BP in the US
Approximately 3.6 million cases of basal cell carcinoma are diagnosed in the US every year